Check-Cap (NASDAQ:CHEK) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Check-Cap (NASDAQ:CHEK) in a report released on Monday. The firm set a “sell” rating on the medical research company’s stock.

Check-Cap Trading Up 2.8 %

Check-Cap stock opened at $2.24 on Monday. Check-Cap has a 12 month low of $1.27 and a 12 month high of $4.63. The stock’s 50 day moving average is $2.24 and its 200-day moving average is $2.63. The company has a market capitalization of $13.10 million, a price-to-earnings ratio of -0.74 and a beta of 0.27.

Hedge Funds Weigh In On Check-Cap

Institutional investors and hedge funds have recently made changes to their positions in the company. Dimensional Fund Advisors LP acquired a new position in shares of Check-Cap in the fourth quarter valued at approximately $31,000. Nantahala Capital Management LLC acquired a new stake in Check-Cap during the fourth quarter worth approximately $69,000. Susquehanna International Group LLP acquired a new stake in Check-Cap during the first quarter worth approximately $57,000. Sabby Management LLC acquired a new stake in Check-Cap during the first quarter worth approximately $91,000. Finally, Citadel Advisors LLC grew its position in Check-Cap by 51.2% during the third quarter. Citadel Advisors LLC now owns 141,319 shares of the medical research company’s stock worth $41,000 after buying an additional 47,868 shares in the last quarter. Institutional investors and hedge funds own 1.07% of the company’s stock.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.